Clinical Trials
<< back to Drug Safety / Pharmacovigilance
- Phase 0 to Phase IV
- Expedited Single case Reporting to EMEA, FDA, MHRA and other Competent Authorities
- Expedited Single case Reporting to Ethics Committees, Institutional Review Boards and Investigators for Clinical Trials
- Periodic analysis & Reporting (SUSAR reports to EU Ethics committees and EU and US style annual Safety update reports)